So complex are migraine headaches that the interplay of both psychological and physiological components is needed to explain and relieve symptoms. The difficulties of defining and delimiting migraine attacks, etiological theories and treatment approaches were reviewed with emphasis on the psychosomatic aspects.
Get full access to this article
View all access options for this article.
References
1.
BakalD. A.Headaches: A biopsychological perspective. Psychological Bulletin, 1975, 82, 369–382.
2.
BekesM.MatosL.RauschJ.TorckE.Treatment of migraine with propranol. Lancet, 1968, 2, 980.
3.
BildR.AdamsH. E.Modification of migraine headaches by cephalic blood volume pulse and EMG biofeedback. Journal of Consulting and Clinical Psychology, 1980, 48, 51–57.
4.
BlanchardE. B.TheobaldD. C.WilliamsonD. A.SilverB. V.BrownD.Temperature biofeedback in treatment of migraine headache. Archives of General Psychiatry, 1978, 35, 581–588.
5.
BlanchardE. B.YoungL. D.Clinical applications of biofeedback training. Archives of General Psychiatry, 1974, 30, 573–589.
6.
BlankN. K.RiednerM. J.Paradoxical response to propranolol in migraine. Lancet, 1973, 2, 1336.
7.
BlauJ. N.Migraine research. British Medical journal, 1971, 2, 751–754.
8.
CallaghanN.The migraine syndrome in pregnancy. Neurology, 1968, 18, 197–201.
9.
CarrollJ. D.Migraine—general management. British Medical Journal, 1971, 2, 756–757.
10.
CavinessV. S.Jr.O'BrienP.Current concepts: Headache. New England Journal of Medicine, 1980, 302, 446–449.
11.
CohenM. J.RicklesW. H.McArthurD. L.Evidence for physiological response stereotypy in migraine headache. Psychosomatic Medicine, 1978, 40, 344–354.
12.
CouchJ. R.HassaneinR.Platelet aggregability in migraine. Neurology, 1977, 27, 843–848.
13.
CouchJ. R.ZieglerD. K.HassaneinR.Amitxyptyline in the prophylaxis of migraine. Neurology, 1976, 26, 121–127.
14.
CrooksJ.StephenS. A.BrassW.Clinical trial of inhaled ergotamine tartrate in migraine. British Medical Journal, 1964, 1, 221–224.
15.
DalessioD. J.Migraine, platelets, and headache prophylaxis. Journal of the American Medical Association, 1978, 239, 52–53.
16.
dePianoF. A.SalzbergH. C.Clinical applications of hypnosis in three psychosomatic disorders. Psychological Bulletin, 1979, 86, 1223–1235.
17.
DiamondS.Therapeutics. New York: Biomedical Information Corp., 1976.
18.
DukesH. T.ViethR.Cerebral arteriography during migraine prodrome and headache. Neurology, 1964, 14, 636–639.
19.
DvilanskyA.RishponS.NathanI.ZolotowZ.KorczynA.Release of platelet 5-hydroxytryptamine by plasma taken from patients during and between migraine attacks. Pain, 1976, 2, 315–318.
20.
ElithornA.Migraine. British Medical Journal, 1969, 4, 411–413.
21.
ElkindA. H.FriedmanA. P.BachmanA.SiegelmanS. S.SacksO. W.Silent retroperitoneal fibrosis associated with methylsergide therapy. Journal of the American Medical Association, 1968, 206, 1041–1044.
22.
EpsteinM. T.HockadayJ. M.HockadayT. D. R.Migraine and reproductive hormones throughout the menstrual cycle. Lancet, 1975, 1, 543–545.
23.
FrankJ. D.Psychiatry, the healthy invalid. American Journal of Psychiatry, 1977, 134, 1349–1355.
24.
FriarL. R.BeattyJ.Migraine: Management by trained control of vasoconstriction. Journal of Consulting and Clinical Psychology, 1976, 44, 46–53.
25.
FriedmanA. P.Reflections on the problem of headache. Journal of the American Medical Association, 1964, 190, 445–447.
26.
FriedmanA. P.ElkindA. H.Appraisal of methylsergide in treatment of vascular headaches of migraine type. Journal of the American Medical Association, 1963, 184, 125–128.
27.
FriedmanA. P.FinleyK. H.GrahamJ. R.KunkleE. C.OstfeldA. M.WolffH. G.Classification of headache. Journal of the American Medical Association, 1962, 179, 717–718.
28.
FriedmanA. P.MerrittH. H.Treatment of headache. Journal of the American Medical Association, 1957, 163, 1111–1117.
29.
FullerG. D.Current status of biofeedback in clinical practice. American Psychologist, 1978, 33, 39–48.
30.
GainerJ. C.Temperature discrimination training in the biofeedback treatment of migraine headache. Journal of Behavior Therapy & Experimental Psychiatry, 1978, 9, 185–187.
31.
GrahamJ. R.Use of a new compound, UML-491 (1-methyl-D-Lysergic acid Butanolamide) in prevention of various types of headache: A pilot study. New England Journal of Medicine, 1960, 263, 1273–1277.
32.
GrahamJ. R.Methylsergide for prevention of headache: Experience in over five hundred patients over three years. New England Journal of Medicine, 1964, 270, 67–72.
33.
GrahamJ. R.MalveaB. P.GrammH. F.Aerosol ergotamine tartrate for migraine and Horton's Syndrome. New England Journal of Medicine, 1960, 263, 802–804.
34.
GrahamJ. R.SubyH. I.LeCompteP. R.SadowskyN. L.Fibriotic disorders associated with methylsergide therapy for headaches. New England Journal of Medicine, 1966, 274, 359–368.
35.
GrantE. C.Relation between headaches from oral contraceptives and development of endometrial arterioles. British Journal of Medicine, 1968, 3, 402–404.
36.
HaningtonE.Preliminary report on tyramine headaches. British Medical Journal, 1967, 2, 550–551.
Henryk-GuttR.ReesW. L.Psychological aspects of migraine. Journal of Psychosomatic Research, 1973, 17, 141–153.
39.
HufferV.Biofeedback: The need for a flexible approach. Psychosomatics, 1979, 20, 413–415.
40.
KimballR. W.FriedmanA. P.Further studies of neurohumoral agents in patients with vascular headaches. Neurology, 1961, 11, 116–119.
41.
KiritzS.MoosR. H.Physiological effects of social environments. Psychosomatic Medicine, 1974, 36, 96–114.
42.
KudrowL.Current aspects of migraine headache. Psychosomatics, 1978, 19, 48–57.
43.
LambleyP.The use of assertive training and psychodynamic insight in the treatment of migraine headache: A case study. Journal of Nervous and Mental Diseases, 1976, 163, 61–64.
44.
LanceJ. W.AnthonyM.SomervilleB.Comparative trial of serotonin antagonists in the management of migraine. British Medical Journal, 1970, 2, 327–330.
45.
LipowskiZ. J.Psychosomatic medicine in the seventies: An overview. American Journal of Psychiatry, 1977, 134, 233–244.
46.
LoneyJ. G.LippM. R.SpitzerR. L.A new method of classification for psychophysiologic disorders. American Journal of Psychiatry, 1978, 135, 304–308.
47.
LucasR. N.Migraine in twins. Journal of Psychosomatic Research, 1977, 20, 147–156.
48.
LucasR. N.FalkowskiW.Ergotamine and methylsergide abuse in patients with migraine. British Journal of Psychiatry, 1973, 122, 199–203.
49.
LuiselliJ. K.MarholinD.SteinmanD. L.SteinmanW. M.Assessing the effects of relaxation training. Behavior Therapy, 1979, 10, 663–668.
50.
LutkerE. R.Treatment of migraine headache by conditioned relaxation: A case study. Behavior Therapy, 1971, 2, 592–593.
51.
Maher-LoughnanG. P.Intensive hypno-autohypnosis in resistant psychosomatic disorders. Journal of Psychosomatic Research, 1975, 19, 361–365.
52.
MahloudjiM.Prevention of migraine. British Medical Journal, 1969, 1, 182–183.
53.
MarcussenR. M.WolffH. G.A formulation of the dynamics of the migraine attack. Psychosomatic Medicine, 1949, 11, 251–256.
54.
MarksI. M.The current status of behavioral psychotherapy: Theory and practice. American Journal of Psychiatry, 1976, 133, 253–261.
McCullochJ.HarperA. M.Phenylethylamine and cerebral blood flow. Neurology, 1977, 27, 817–821.
58.
MillerN. E.Learning of visceral and glandular responses. Science, 1969, 163, 434–445.
59.
MillerN. E.Biofeedback and visceral learning. Annual Review of Psychology, 1978, 29, 373–404.
60.
MitchellK. R.A psychological approach to the treatment of migraine. British Journal of Psychiatry, 1971, 119, 533–534.
61.
MitchellK. R.MitchellD. M.Migraine: An exploratory treatment application of programmed behaviour therapy techniques. Journal of Psychosomatic Research, 1971, 15, 137–157.
62.
MitchellK. R.WhiteR. G.Behavioral self-management: An application to the problem of migraine headaches. Behavior Therapy, 1977, 8, 213–221.
63.
OlbrischM. E.Psychotherapeutic interventions in physical health. American Psychologist, 1977, 32, 761–771.
64.
OstfeldA. M.ChapmanL. F.GoodellH.WolffH. G.Studies in headache: Summary of evidence concerning a noxious agent active locally during migraine headache. Psychosomatic Medicine, 1957, 19, 199–208.
65.
PassmoreR.RobsonJ. D. (Eds.) A companion to medical studies. London: Blackwell, 1974. Vol. 3. Pp. 34, 156–158.
66.
PaulleyJ. W.HaskelD. A.The treatment of migraine without drugs. Journal of Psychosomatic Research, 1975, 19, 367–374.
67.
PhilipsC.Headache and personality. Journal of Psychosomatic Research, 1976, 20, 535–542.
68.
PhillipsB. M.Oral contraceptive drugs and migraine. British Medical Journal, 1968, 2, 99.
69.
PomerleauO.Behavioral medicine. American Psychologist, 1979, 34, 654–663.
70.
PoserC. M.Papaverine in prophylactic treatment of migraine. Lancet, 1974, 1, 1290.
71.
PriceK. P.The application of behavior therapy to the treatment of psychosomatic disorders: Retrospect and prospect. Psychotherapy, 1974, 11, 138–154.
72.
ReesL.The premenstrual tension syndrome and its treatment. British Medical Journal, 1953, 1, 1007–1014.
73.
RichardsW.The fortification illusions of migraines. Scientific American, 1971, 224, 88–97.
74.
RosenJ. C.WiensA. N.Changes in medical problems and use of medical services following psychological intervention. American Psychologist, 1979, 34, 420–431.
SaperJ.Migraine: II. Treatment. Journal of the American Medical Association, 1978, 239, 2480–2484.
77.
SargentJ. D.GreenE. E.WaltersE. D.Preliminary report on the use of autogenic feedback training in the treatment of migraine and tension headaches. Psychosomatic Medicine, 1973, 35, 129–139.
78.
SchnarchD. M.HunterJ. E.Migraine incidence in clinical vs. nonclinical populations. Psychosomatics, 1980, 21, 314–325.
79.
SchwartzG. E.Biofeedback in therapy: Some theoretical and practical issues. American Psychologist, 1973, 28, 666–673.
80.
SchwartzG. E.DavidsonR. J.GolemanD. J.Patterning of cognitive and somatic processes in the self-regulation of anxiety: Effects of meditation versus exercise. Psychosomatic Medicine, 1978, 40, 321–328.
81.
SherwinD.A new method for treating headaches. American Journal of Psychiatry, 1979, 136, 1181–1183.
82.
SomervilleB. W.The role of progesterone in menstrual migraine. Neurology, 1971, 21, 853–859.
StolzS. B.WienckowskiL. A.BrownB. S.Behavior modification: A perspective on critical issues. American Psychologist, 1975, 20, 1027–1048.
85.
TandonR. N.SurB. K.NathK.Effect of reserpine injections in migrainous and normal control subjects, with estimations of urinary 5-hydroxyindoleacetic acid. Neurology, 1969, 19, 1073–1079.
86.
TurinA.JohnsonW. G.Biofeedback therapy for migraine headache. Archives of General Psychiatry, 1976, 33, 517–519.
87.
TurkD. C.MeichenbaumD. H.BermanW. H.Application of biofeedback for the regulation of pain: A critical review. Psychological Bulletin, 1979, 86, 1322–1328.
88.
VolansG. N.Absorption of effervescent aspirin during migraine. British Medical Journal, 1974, 4, 265–269.
89.
WatersW. E.Controlled clinical trial of ergotamine tartrate. British Medical Journal, 1970, 2, 325–327.
90.
WatersW. E.Migraine: Intelligence, social class, and familial prevalence. British Medical Journal, 1971, 1, 77–81.
91.
WhittyC. W.HockadayJ. M.Migraine: A follow-up study of 92 patients. British Medical Journal, 1968, 1, 735–736.
92.
WhittyC. W.HockadayJ. M.WhittyM. M.The effect of oral contraceptives on migraine. Lancet, 1966, 1, 856–859.
93.
WickramaskeraI. E.Temperature feedback for the control of migraine. Journal of Behavior Therapy & Experimental Psychiatry, 1973, 4, 343–345.
94.
WilkinsonM.Migraine—treatment of acute attack. British Medical Journal, 1971, 2, 754–755.
95.
WrightL.Conceptualizing and defining psychosomatic disorders. American Psychologist, 1977, 32, 625–628.
96.
ZieglerD. K.Headache syndromes: Problems of definition. Psychosomatics, 1979, 20, 443.
97.
ZieglerD. K.HassaneinR.HassaneinK.Headache syndromes in a headache prone population. Journal of Chronic Diseases, 1972, 25, 353–363.
